Able Laboratories Inc (857171) SEC Filing 10-Q Quarterly report for the period ending Wednesday, March 31, 2004

Able Laboratories Inc

CIK: 857171

View differences made from one quarter to another to evaluate Able Laboratories Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Able Laboratories Inc.


Assess how Able Laboratories Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Able Laboratories Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2004 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 857171
Form Type: 10-Q Quarterly Report
Accession Number: 0001072613-04-000969
Submitted to the SEC: Fri May 07 2004 4:17:56 PM EST
Accepted by the SEC: Fri May 07 2004
Period: Wednesday, March 31, 2004
Industry: In Vitro And In Vivo Diagnostic Substances

External Resources:

Bookmark the Permalink: